Ebola Fever Pipeline Market Landscape Report 2025: Emerging Therapies, Development Activities, Progress in Drug Development and Clinical Trials
March 05, 2025 10:38 ET
|
Research and Markets
Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Ebola Fever - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.This report captures an exhaustive analysis of the...
$65.5 Bn Cancer Monoclonal Antibodies Market Analysis by Antibody Type, Medication Type, Application, End-User, and Region 2025-2033
February 24, 2025 11:20 ET
|
Research and Markets
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Market by Antibody Type, Medication Type, Application, End-User, and Region 2025-2033" report has been added to ...
Cancer Monoclonal Antibody (mAB) Collaboration and Licensing Deals Trends and Analysis Report 2024: Access 599 Agreements Signed by the World's Leading Life Science Companies
January 31, 2025 09:08 ET
|
Research and Markets
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Cancer Monoclonal...
$11.6 Billion Biologics Fill Finish Services Market Industry Trends and Global Forecasts to 2035: Growing Demand for Biologics and Technological Advancements in Fill Finish Operations
January 29, 2025 07:03 ET
|
Research and Markets
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Biologics Fill Finish Services Market: Industry Trends and Global Forecasts to 2035" report has been added to ResearchAndMarkets.com's offering. The...
Biologics Market Research Report 2024-2030: Technological Innovations in Monoclonal Antibodies and Gene Therapies Fueling Developments and Growth
January 28, 2025 08:38 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Biologics was estimated...
Growth Trends in the Immunotherapy Drugs Industry 2025-2030, by Drug Type, Indication and Region - Revenues to Grow from $268.6 Billion in 2024 to a Projected $577.2 Billion by 2030
January 21, 2025 04:08 ET
|
Research and Markets
Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs Market Size, Share & Trends Analysis by Drug Type, Indication, and Region, 2025-2030" report has been added to ...
Engineered Multispecific Antibodies Innovation Research Report 2024: Patent Trends Show a Noticeable Surge in 2023 with Regeneron, Roche, and Amgen Emerging as the Top Patent Filers
January 17, 2025 04:57 ET
|
Research and Markets
Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: Engineered Multispecific antibodies" report has been added to ResearchAndMarkets.com's offering.Engineered multispecific...
Biotherapeutics Market Insights 2025, Analysis and Forecast to 2030: Insulin Demand Soars Amid Diabetes Epidemic, Sees $40 Billion Opportunity
January 13, 2025 06:40 ET
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Biotherapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type" report...
Antibodies Contract Manufacturing Market Research 2024 with Global Long-term Forecasts to 2035: Expansion of Emerging Markets, Personalized Medicine, Therapeutic Antibodies Demand Fueling Growth
January 08, 2025 11:42 ET
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Antibodies Contract Manufacturing Market by Product, by Source, by End-User, and By Region" report has been added to ResearchAndMarkets.com's...
8MM Respiratory Syncytial Virus Prophylaxis Market Drug Analysis Report: Prophylactic Options to Continue to Diversify Due to Strength of Late-Stage Pipeline - Forecast to 2030
December 20, 2024 10:05 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus Prophylaxis: Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's...